Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.

McArthur MA, Maciel M Jr, Pasetti MF.

Vaccine. 2017 Dec 14;35(49 Pt A):6803-6806. doi: 10.1016/j.vaccine.2017.05.034. Epub 2017 May 27.

2.

Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling.

Pasztoi M, Bonifacius A, Pezoldt J, Kulkarni D, Niemz J, Yang J, Teich R, Hajek J, Pisano F, Rohde M, Dersch P, Huehn J.

Cell Mol Life Sci. 2017 Aug;74(15):2839-2850. doi: 10.1007/s00018-017-2516-y. Epub 2017 Apr 4.

3.

Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.

Pitisuttithum P, Islam D, Chamnanchanunt S, Ruamsap N, Khantapura P, Kaewkungwal J, Kittitrakul C, Luvira V, Dhitavat J, Venkatesan MM, Mason CJ, Bodhidatta L.

Clin Vaccine Immunol. 2016 Jul 5;23(7):564-75. doi: 10.1128/CVI.00665-15. Print 2016 Jul.

4.

Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Chakraborty S, Harro C, DeNearing B, Bream J, Bauers N, Dally L, Flores J, Van de Verg L, Sack DA, Walker R.

Clin Vaccine Immunol. 2016 Apr 4;23(4):315-25. doi: 10.1128/CVI.00608-15. Print 2016 Apr.

5.

TIR Domain-Containing Adapter-Inducing Beta Interferon (TRIF) Mediates Immunological Memory against Bacterial Pathogens.

Kanagavelu S, Flores C, Termini JM, Romero L, Riveron R, Ruiz J, Arditi M, Schesser K, Fukata M.

Infect Immun. 2015 Nov;83(11):4404-15. doi: 10.1128/IAI.00674-15. Epub 2015 Sep 8.

6.

Shigella manipulates host immune responses by delivering effector proteins with specific roles.

Ashida H, Mimuro H, Sasakawa C.

Front Immunol. 2015 May 7;6:219. doi: 10.3389/fimmu.2015.00219. eCollection 2015. Review.

7.

TLR-4 cooperates with Dectin-1 and mannose receptor to expand Th17 and Tc17 cells induced by Paracoccidioides brasiliensis stimulated dendritic cells.

Loures FV, Araújo EF, Feriotti C, Bazan SB, Calich VL.

Front Microbiol. 2015 Mar 31;6:261. doi: 10.3389/fmicb.2015.00261. eCollection 2015.

8.

Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.

Kim JO, Rho S, Kim SH, Kim H, Song HJ, Kim EJ, Kim RY, Kim EH, Sinha A, Dey A, Yang JS, Song MK, Nandy RK, Czerkinsky C, Kim DW.

Clin Vaccine Immunol. 2015 Apr;22(4):381-8. doi: 10.1128/CVI.00661-14. Epub 2015 Feb 4.

9.

Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Chen X, Choudhari SP, Martinez-Becerra FJ, Kim JH, Dickenson NE, Toth RT 4th, Joshi SB, Greenwood JC 2nd, Clements JD, Picking WD, Middaugh CR, Picking WL.

Infect Immun. 2015 Jan;83(1):292-9. doi: 10.1128/IAI.02457-14. Epub 2014 Nov 3.

10.

B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.

Nothelfer K, Arena ET, Pinaud L, Neunlist M, Mozeleski B, Belotserkovsky I, Parsot C, Dinadayala P, Burger-Kentischer A, Raqib R, Sansonetti PJ, Phalipon A.

J Exp Med. 2014 Jun 2;211(6):1215-29. doi: 10.1084/jem.20130914. Epub 2014 May 26.

11.

Vaccine approaches for multidrug resistant Gram negative infections.

Campfield B, Chen K, Kolls JK.

Curr Opin Immunol. 2014 Jun;28:84-9. doi: 10.1016/j.coi.2014.02.002. Epub 2014 Mar 15. Review.

12.

Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF.

J Immunol. 2014 Feb 15;192(4):1630-40. doi: 10.4049/jimmunol.1302743. Epub 2014 Jan 22.

13.

E2~Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis.

Pruneda JN, Smith FD, Daurie A, Swaney DL, Villén J, Scott JD, Stadnyk AW, Le Trong I, Stenkamp RE, Klevit RE, Rohde JR, Brzovic PS.

EMBO J. 2014 Mar 3;33(5):437-49. doi: 10.1002/embj.201386386. Epub 2014 Jan 20.

14.

The role of T helper (TH)17 cells as a double-edged sword in the interplay of infection and autoimmunity with a focus on xenobiotic-induced immunomodulation.

Hemdan NY, Abu El-Saad AM, Sack U.

Clin Dev Immunol. 2013;2013:374769. doi: 10.1155/2013/374769. Epub 2013 Sep 12. Review.

15.

Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL.

Infect Immun. 2013 Dec;81(12):4470-7. doi: 10.1128/IAI.00859-13. Epub 2013 Sep 23.

16.

Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.

Heine SJ, Diaz-McNair J, Martinez-Becerra FJ, Choudhari SP, Clements JD, Picking WL, Pasetti MF.

Vaccine. 2013 Jun 19;31(28):2919-29. doi: 10.1016/j.vaccine.2013.04.045. Epub 2013 May 2.

17.

Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics.

Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB, Levy D.

PLoS One. 2013 Apr 2;8(4):e59465. doi: 10.1371/journal.pone.0059465. Print 2013.

18.

Shigella impairs T lymphocyte dynamics in vivo.

Salgado-Pabón W, Celli S, Arena ET, Nothelfer K, Roux P, Sellge G, Frigimelica E, Bousso P, Sansonetti PJ, Phalipon A.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4458-63. doi: 10.1073/pnas.1300981110. Epub 2013 Feb 15.

19.

Interindividual variability and co-regulation of DNA methylation differ among blood cell populations.

Jacoby M, Gohrbandt S, Clausse V, Brons NH, Muller CP.

Epigenetics. 2012 Dec 1;7(12):1421-34. doi: 10.4161/epi.22845. Epub 2012 Nov 14.

20.

Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers.

Teo I, Toms SM, Marteyn B, Barata TS, Simpson P, Johnston KA, Schnupf P, Puhar A, Bell T, Tang C, Zloh M, Matthews S, Rendle PM, Sansonetti PJ, Shaunak S.

EMBO Mol Med. 2012 Sep;4(9):866-81. doi: 10.1002/emmm.201201290. Epub 2012 Aug 6.

Supplemental Content

Support Center